Should I get germline genetic testing if I have cancer

May 19, 2026Navis AI

Ask Navis about your situation

This answer is general. Get one about your specific case — no signup, answered right here.

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Germline Genetic Testing for Cancer Patients: What You Should Know

This is an important question that many cancer patients face. Let me explain what germline testing is, who typically benefits from it, and how to think about whether it might be right for you.

What Is Germline Genetic Testing?

Germline testing looks for inherited genetic mutations—changes in your DNA that you were born with and carry in every cell of your body. These mutations can increase your lifetime risk of developing cancer. This is different from somatic testing, which looks at mutations only in your cancer cells.

Who Should Consider Germline Testing?

According to NCCN (National Comprehensive Cancer Network) Guidelines, germline testing is recommended for cancer patients who meet certain criteria, including:

  • Age at diagnosis: Diagnosed with cancer at a younger age than typical
  • Family history: Multiple relatives with cancer, especially the same type
  • Specific cancer types: Certain cancers have stronger hereditary links (breast, ovarian, pancreatic, prostate, colorectal)
  • Specific mutations in your tumor: If your cancer cells show certain mutations (like BRCA1/2, Lynch syndrome genes)
  • Ancestry: Certain ethnic backgrounds have higher carrier rates for specific mutations

Why This Matters

If you carry a germline mutation, it affects:

  • Your future health: Increased risk of additional cancers
  • Your family members: They may have inherited the same mutation
  • Treatment decisions: Some mutations may influence your current cancer treatment options
  • Screening and prevention: You and relatives may benefit from enhanced surveillance or preventive measures

Questions to Ask Your Oncology Team

  1. Based on my cancer type, age, and family history, do I meet criteria for germline testing?
  2. If I test positive for a hereditary cancer syndrome, how would that change my treatment plan?
  3. What are the implications for my family members if I carry a mutation?
  4. Should I see a genetic counselor before or after testing?
  5. What specific genes would be tested, and what would the results mean for my future cancer risk?

Important Considerations

The American Cancer Society emphasizes that genetic counseling before testing helps you understand:

  • What results might mean
  • Psychological impact of learning you carry a mutation
  • Privacy and insurance implications
  • Family communication considerations

Testing is a personal decision—a positive result doesn't mean you will develop cancer, but rather that your risk is elevated. Your care team can help you weigh the benefits and considerations specific to your situation.


This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

Ask Navis about your case

That answer is general. Ask about your specific situation — no signup, answered right here.

Facing this with someone you love?

Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.

Start a care circle →

Related Questions

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

Return ONLY valid JSON. No markdown. Based on 2 medical records: DOCUMENT: IMG_2090.png (Imaging Report) Date:...

```json { "bottomLine": "Your Ga-68 Dotatate PET scans from June and August 2026 show stable metastatic pancreatic neuroendocrine tumor NET with liv

We are in the UK royal marsden. It is kind of hopeless or how to say? Is there any immunetherapy worth to pursue or...

TL;DR: Diffuse midline gliomas DMGs with H3K27M are very challenging, but immunotherapy and targeted approaches are actively being researched—the Roya

It is my daughter she completed 6 weeks of radio and tmz now she is on 3rd cycle of tmz 200mg. We are doing low meth...

TL;DR: Your daughter's treatment plan radiation + TMZ chemotherapy is standard for diffuse midline glioma, and her biomarkers MGMT methylated, EGFR A2

It is h3k27 altered dmg h3k27m negative, egfr a289v myc tp53 mgmt methylated

Your tumor has specific genetic changes H3K27, EGFR, MYC, TP53, MGMT that your doctors will use to guide treatment decisions—these findings help deter